Clinical trials and clinical research are essential for advancing medical knowledge, improving patient care, and developing new treatments and therapies for the patients who need them. Execution of this vital work requires collaboration, innovation, and strategic decision-making. Now in its 15th year of fostering these joint efforts to advance our medical knowledge inclusive of all stakeholders, SCOPE Summit 2024 will take place February 11-14, 2024, in Orlando, FL, at the Rosen Shingle Creek. Over four stimulating days of in-depth discussions and networking in 28 different conferences, three plenary keynote sessions, the 8th annual Participant Engagement Awards, the inaugural Site Innovation Award, and special cross-department panels, the programming focuses on advances and innovative solutions in all aspects of clinical trial innovation, planning, management, operations, and investment. SCOPE welcomes more than 3,300 attendees and 850 different organizations from 27 countries in clinical operations, clinical trials, innovation, and research.
Join TransCelerate for the following sessions:
- “The Next Horizon of Clinical Research: A Multi-Stakeholder Panel on Integrating Research into the Care Continuum” with Janice Chang, CEO, TransCelerate BioPharma; Uli Broedl, Corporate Senior Vice President and Head of Global Clinical Development & Operations, Boehringer Ingelheim; and Christoph Koenen, Head of Global Development & Clinical Operations, Pharmaceuticals R&D, Bayer (Keynote session)
- “Enabling Greater Flexibility in Conducting Clinical Trials-Lessons Learned” (TransCelerate’s Modernizing Clinical Trial Conduct Initiative) with Joachim Lovin, Senior Business Analyst, Novo Nordisk
- “Diversity by Design: Accessing Solutions from the Start” with Sandra Amaro, Head of Clinical Trial Diversity, Pfizer (Diversity of Participants in Clinical Trials Initiative)
- “Individual Participant Data Return Options: A Paradigm Shift in Personalizing the Clinical Trial Experience for Patients and their Care Partners” with Jean Sposaro, Global Drug Development Operations Industry Collaborations Director, BMS (Individual Participant Data Return Initiative)
- “Optimizing Patient Choice, Flexibility, and Outcomes by Personalizing the Clinical Trial Experience” with Joachim Lovin, Senior Business Analyst, Novo Nordisk (Patient Experience Initiative)
- “Decentralized Clinical Trials Implementation Challenges and Solutions” with Rob DiCicco, Vice President Portfolio Management, TransCelerate BioPharma
- “Digital Data Flow: Digitalizing Clinical Protocol Information to Accelerate Clinical Research and Pharma to Healthcare Interoperability with Rob DiCicco, Vice President Portfolio Management, TransCelerate BioPharma